B01AC11 • iloprost • Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin
Iloprost is a synthetic analog of prostacyclin used for the treatment of pulmonary arterial hypertension and severe Raynaud's phenomenon. It works by dilating blood vessels and inhibiting platelet aggregation, improving blood flow.
The medication is administered via inhalation or intravenous infusion, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include headache, dizziness, nausea, or facial flushing. In rare cases, severe hypotension or bleeding may occur.
Iloprost is not recommended for patients with hypersensitivity to this medication or conditions that increase the risk of bleeding.
Substance: iloprost
Date of last drug list: 01-03-2024
Commercial code: W67924009
Concentration: 10mcg / ml
Pharmaceutical form: inhalation solution by nebulization
Quantity: 168
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: ZENTIVA, K.S - REPUBLICA CEHA
Holder: ZENTIVA K.S. - REPUBLICA CEHA
Number: 14040/2021/09
Shelf life: 3 years